Glenmark Life Sciences Ltd.

GLS

Market Cap
₹7,787 Cr.
P/E
15.40

Glenmark Life Sciences Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Depreciation Effect
Company is depreciating a greater percentage of assets. This is contributing to a reduction in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Unable to calculate due to limited data
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has decreased over last 10 years more due to earnings
ROE
ROE has decreased vs 10 year trend
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a premium to 3yr historic valuations
Promoter Holding
Promoter has not sold any shares in the last 90 days
ROE
Latest
21.84%
3yr Average
29.64%
5yr Average
77.76%
Net Profit Margin
Latest
21.61%
3yr Average
19.99%
5yr Average
20.48%
ROCE
Latest
28.63%
3yr Average
43.01%
5yr Average
95.75%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Customer Segment

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic

locked
Source
|
Latest
|
locked
Historic

Customer Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up - Geography Wise

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (No)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Glenmark Life Sciences Ltd.
    Glenmark Life Sciences: Execution and Governance Can Drive the Stock Much Higher - Moneylife
    View the discussion on ValuePickr
    timeline
    Sign Up for Free